Overview:
The bioprocess
technology market share is expected to reach USD 19.84 Billion by 2032 at
7.1% CAGR during the forecast period 2023-2032.
Bioprocess Technology Market Size is witnessing at present an
unprecedented growth due to revolutionary changes effected upon it by
technological advancements. The impact is aptly
backed by demands generated by the healthcare sector. The global
Bioprocess Technology market is expected to witness significant growth during
the forecast period (2017-2022), reveals Market Research Future (MRFR) in a
detailed analysis of the said market. Bioprocess
Technology involves deriving living cells or components and obtains desired results to boost
pharmaceuticals or chemical sector. The report incorporates multiple factors
that can promote Bioprocess Technology market further such as its growing use
in developing new drugs & treatments, food processing, thermal design of
biomedical devices, and effective
application in pollution control & global warming. An in-depth review of
the segments has also been included for a
better understanding of the bioprocess
technology consultants market in coming
years.
However, the regulatory process often delays the approval of new drugs which can
increase the production cost by a significant
margin. This can put a leash on the
expected Bioprocess Technology Market Share, growth during the forecast
period.
Bioprocess Technology
Market Overview and Information, by Type (flow
cytometry, cell culture, cell expansion, cell line development, virus
infiltration), by Application (biopharmaceuticals, specialty products and
industrial chemicals, environmental management aid), by End Users (hospitals,
research Centers, medical institutions)
Key Players:
Some of the Bioprocess
Technology Market Players profiled in this report are
Merck Millipore (Germany),
Thermo Fisher Scientific, Inc.
(U.S.),
Becton,
Dickinson and Company (U.S.),
Danaher Corporation (U.S.),
Lonza Group AG (Switzerland),
Sartorius Stedim Biotech S.A
(France),
Corning, Inc. (U.S.),
Bio-Rad Laboratories (U.S.),
Charles River Laboratories
(U.S.), and
others.
Segmentation:
The global Bioprocess Technology
Market Outlook can be segmented by
type, application, and end-users.
·
Type-based segmentation of
the Bioprocess Technology market includes
cell culture, cell expansion, flow cytometry, cell line development, and virus infiltration. Cell culture has
diverse application in various sectors which gives it much traction, and it has become a necessary part in treating
chronic diseases.
·
Application-wise, the Bioprocess Technology market
comprises biopharmaceuticals, specialty products, industrial chemicals, and environment management aid.
Biopharmaceuticals’ prosperous run is to continue owing to its widespread
functioning area as it has impacted common medicines to chronic diseases.
Furthermore, petrochemicals can propel the demand for industrial chemicals in coming years.
·
Based on end-users, the Bioprocess Technology market
consists hospitals, research labs and
centers, medical institutions and others. Research labs and centers to gain the
most owing to private and government investments in the field.
Regional
Analysis:
Region-specific analysis of the Bioprocess Technology
Market Insights Report includes
North America, Europe, Asia Pacific (APAC), and the Middle East & Africa
(MEA).
North America’s growth can be attributed to its ability to fetch the
maximum revenue in the global market. Infrastructural superiority can be considered as a boon for the regional
market. Furthermore, healthcare is receiving much funding which is directly
impacting the Bioprocess Technology
market by generating demand for pharmaceutical drugs. Governments and private
investors are also spending much in search for new Bioprocess Technology-based
products.
Europe is also drawing significant
attention from the global market by providing excellent infrastructure for
research and development in this sector. However, the APAC is the fastest
growing region and is touted to influence the market considerably in coming
years. Growing population and revamped healthcare sector can provide the
much-needed thrust to the regional market.
Market Insight:
Strategies employed by the bigshots in the sector help in both individual
and holistic growth of the Bioprocess Technology
market. These strategies include mergers, acquisitions, product launch, and other methods and better the market
portfolio of companies. For instance, Charles River Laboratories has recently
acquired MPI Research, a non-clinical contract research organization (CRO) that provides testing
services to biopharmaceutical and medical device companies across the globe.
Their market rival, Thermo Fisher Scientific, Inc. signed an agreement with
Roper Technologies to acquire Gatan, which can ensure their market profile
upgradation.
Industry News:
·
Novartis
and Gilead/Kite have got approval for their respective
medicines Kymriah and Yescarta, two cell-therapy biotherapeutic medicine which
can significantly trigger monoclonal antibody industry prospect.
About US:
Market Research Future (MRFR) enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
No comments:
Post a Comment